ReviewFrontiers in oncology2026

Macrophage phagocytosis checkpoints in DLBCL immunotherapy: an evidence-maturity framework from CD47 to CD200.

Shasha Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.